+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Cidara Therapeutics Inc (CDTX) - Financial and Strategic SWOT Analysis Review

  • ID: 4284703
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida infections; CD101 topical, for prevention of vulvovaginal candidiasis and recurrent VVC; CD201, a bispecific antimicrobial immunotherapy that is being developed for multi-drug resistant bacterial infections, and others. The company develops cloudbreak, an immunotherapy platform, which helps to create compounds that direct a patient’s immune cells to strike and kill pathogens, which cause infectious diseases. Cidara is headquartered in San Diego, California, the US.

Cidara Therapeutics Inc Key Recent Developments

Mar 01, 2018: Cidara Appoints Chrysa Mineo As Independent Director
Feb 27, 2018: Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 08, 2017: Cidara Provides Corporate Update and Reports Third Quarter 2017 Financial Results
Sep 07, 2017: Cidara Therapeutics to Participate in Keynote Panel Discussion at the 2017 World Antimicrobial Resistance Congress
Aug 09, 2017: Cidara Provides Corporate Update and Reports Second Quarter 2017 Financial Results

This comprehensive SWOT profile of Cidara Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cidara Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Cidara Therapeutics Inc - Key Information
  • Cidara Therapeutics Inc - Overview
  • Cidara Therapeutics Inc - Key Employees
  • Cidara Therapeutics Inc - Key Employee Biographies
  • Cidara Therapeutics Inc - Key Operational Heads
  • Cidara Therapeutics Inc - Major Products and Services
  • Cidara Therapeutics Inc - History
  • Cidara Therapeutics Inc - Company Statement
  • Cidara Therapeutics Inc - Locations And Subsidiaries
  • Cidara Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Cidara Therapeutics Inc - Business Description
  • Cidara Therapeutics Inc - Corporate Strategy
  • Cidara Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cidara Therapeutics Inc - Strengths
  • Cidara Therapeutics Inc - Weaknesses
  • Cidara Therapeutics Inc - Opportunities
  • Cidara Therapeutics Inc - Threats
  • Cidara Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Cidara Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Cidara Therapeutics Inc, Key Information
  • Cidara Therapeutics Inc, Key Ratios
  • Cidara Therapeutics Inc, Share Data
  • Cidara Therapeutics Inc, Major Products and Services
  • Cidara Therapeutics Inc, History
  • Cidara Therapeutics Inc, Key Employees
  • Cidara Therapeutics Inc, Key Employee Biographies
  • Cidara Therapeutics Inc, Key Operational Heads
  • Cidara Therapeutics Inc, Other Locations
  • Cidara Therapeutics Inc, Subsidiaries
  • Cidara Therapeutics Inc, Key Manufacturing facilities
  • Cidara Therapeutics Inc, Key Competitors
  • Cidara Therapeutics Inc, SWOT Analysis
  • Cidara Therapeutics Inc, Ratios based on current share price
  • Cidara Therapeutics Inc, Annual Ratios
  • Cidara Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cidara Therapeutics Inc, Performance Chart
  • Cidara Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3